Lv1
20 积分 2021-09-23 加入
A Quantitative Framework to Evaluate Proarrhythmic Risk in a First‐in‐Human Study to Support Waiver of a Thorough QT Study
1个月前
已完结
Evaluation of Calibration Curve–Based Approaches to Predict Clinical Inducers and Noninducers of CYP3A4 with Plated Human Hepatocytes
2个月前
已完结
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET‐dysregulated solid tumours
2个月前
已完结
Preclinical Comparison of the Blood–brain barrier Permeability of Osimertinib with Other EGFR TKIs
3个月前
已完结
Clinical Drug–Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib
3个月前
已完结
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overview
4个月前
已完结
Exploratory food effect assessment in patients in early clinical development of oncology drugs
4个月前
已完结
An FDA oncology analysis of antibody-drug conjugates
5个月前
已完结
皖公网安备34019202002308
